Qi F, Chen Y, Han Y, Jiang P, et al. EGFR-TKI monotherapy versus combination therapy as first-line treatment for EGFR-mutant NSCLC with brain metastases: a real-world comparison analysis. BMC Cancer 2026 May 20. doi: 10.1186/s12885-026-16193.
PMID: 42163236